| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Feb 25 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 20,000 | 0.00 | 205,436 |
| 9 Feb 25 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 20,000 | 0.00 | 0 |
| 4 Feb 25 | COLL Collegium Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 12,726 | 0.00 | 12,726 |
| 6 Jan 25 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 75,134 | 0.00 | 185,436 |
| 6 Jan 25 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 75,134 | 0.00 | 75,133 |
| 5 Jan 25 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,667 | 0.00 | 110,302 |
| 5 Jan 25 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 12,667 | 0.00 | 25,333 |
| 3 Jan 25 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 40,000 | 330.40 k | 40,000 |
| 16 Aug 24 | EYPT EyePoint Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 7.88 | 3,173 | 25.00 k | 97,635 |
